STOCK TITAN

Emergent Biosolutions, Inc. (EBS) EPS by Year

EBS

Emergent Biosolutions, Inc. earned $0.93 per diluted share in fiscal year 2025. This represents an increase of 125.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a loss of $3.47 per diluted share. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Emergent Biosolutions, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) $0.93
YoY +125.8%
5Y CAGR -30.4%
10Y CAGR -4.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

EBS EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
EPS (Diluted)-$3.47$0.93+125.8%-$3.60+75.8%-$14.85-251.9%-$4.22-203.9%$4.06-28.5%$5.68+446.2%$1.04-14.8%$1.22-28.7%$1.71+51.3%$1.13-19.9%$1.41+60.2%$0.88+3.5%$0.85+30.8%$0.65+1.6%$0.64

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

EBS EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)-$3.49-1486.4%$0.07-$0.96-68.4%$0.91-55.8%-$0.22+95.9%$1.19+600.0%-$0.57+35.2%$2.06+140.6%-$5.38-4.3%$0.17+104.6%-$0.88+34.3%-$5.08-190.3%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Emergent Biosolutions, Inc. financials

Frequently Asked Questions

What was Emergent Biosolutions, Inc.'s diluted earnings per share in fiscal year 2025?

Emergent Biosolutions, Inc. earned $0.93 per diluted share in fiscal year 2025.

How fast is Emergent Biosolutions, Inc.'s diluted earnings per share growing?

Emergent Biosolutions, Inc. (EBS) diluted earnings per share rose by 125.8% year over year, from -$3.60 to $0.93 in fiscal year 2025.

What is Emergent Biosolutions, Inc.'s diluted earnings per share over the last twelve months?

Emergent Biosolutions, Inc. (EBS) reported a loss of $3.47 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Emergent Biosolutions, Inc. (EBS) diluted earnings per share went from $0.64 in fiscal year 2011 to $0.93 in fiscal year 2025.

Emergent Biosolutions, Inc. (EBS) reported -$3.49 in diluted earnings per share in Q2 2026. This represents a decrease of 1486.4% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Emergent Biosolutions, Inc. (EBS) reported on that line in every period on record.